223 related articles for article (PubMed ID: 11145222)
21. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
23. Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.
Wu SJ; Don TM; Lin CW; Mi FL
Mar Drugs; 2014 Nov; 12(11):5677-97. PubMed ID: 25421323
[TBL] [Abstract][Full Text] [Related]
24. Dulbecco's modified eagle's medium and minimum essential medium--which one is more preferred for establishment of Caco-2 cell monolayer model used in evaluation of drug absorption?
Wu XW; Wang RF; Yuan M; Xu W; Yang XW
Pharmazie; 2013 Oct; 68(10):805-10. PubMed ID: 24273884
[TBL] [Abstract][Full Text] [Related]
25. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
26. Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines.
Thwaites DT; Hirst BH; Simmons NL
Pharm Res; 1993 May; 10(5):674-81. PubMed ID: 8321830
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
28. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells.
Tomita M; Hayashi M; Awazu S
J Pharm Sci; 1996 Jun; 85(6):608-11. PubMed ID: 8773957
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
30. In vitro assessment of epithelial electrical resistance in human esophageal and jejunal mucosae and in Caco-2 cell layers.
Björkman E; Casselbrant A; Lundberg S; Fändriks L
Scand J Gastroenterol; 2012 Nov; 47(11):1321-33. PubMed ID: 23003564
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Pharmacol; 1999 Jan; 51(1):27-33. PubMed ID: 10197414
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
33. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Takahashi Y; Kondo H; Yasuda T; Watanabe T; Kobayashi S; Yokohama S
Int J Pharm; 2002 Oct; 246(1-2):85-94. PubMed ID: 12270611
[TBL] [Abstract][Full Text] [Related]
34. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
[TBL] [Abstract][Full Text] [Related]
35. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media.
Ranaldi G; Consalvo R; Sambuy Y; Scarino ML
Toxicol In Vitro; 2003; 17(5-6):761-7. PubMed ID: 14599474
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists.
Gan LS; Yanni S; Thakker DR
Pharm Res; 1998 Jan; 15(1):53-7. PubMed ID: 9487546
[TBL] [Abstract][Full Text] [Related]
37. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2).
Kowapradit J; Opanasopit P; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Ruktanonchai U; Sajomsang W
AAPS PharmSciTech; 2008; 9(4):1143-52. PubMed ID: 19009354
[TBL] [Abstract][Full Text] [Related]
38. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.
Feighery LM; Cochrane SW; Quinn T; Baird AW; O'Toole D; Owens SE; O'Donoghue D; Mrsny RJ; Brayden DJ
Pharm Res; 2008 Jun; 25(6):1377-86. PubMed ID: 18163202
[TBL] [Abstract][Full Text] [Related]
39. Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: comparison with isolated rat jejunum and colon.
Tanaka Y; Taki Y; Sakane T; Nadai T; Sezaki H; Yamashita S
Pharm Res; 1995 Apr; 12(4):523-8. PubMed ID: 7541133
[TBL] [Abstract][Full Text] [Related]
40. Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs.
Brown JR; Collett JH; Attwood D; Ley RW; Sims EE
Int J Pharm; 2002 Oct; 245(1-2):133-42. PubMed ID: 12270250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
